Addison Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.7K Hold
140
﹤0.01% 619
2025
Q4
$12.6K Hold
140
﹤0.01% 603
2025
Q3
$13.8K Hold
140
﹤0.01% 587
2025
Q2
$12.8K Hold
140
﹤0.01% 596
2025
Q1
$15.8K Hold
140
﹤0.01% 529
2024
Q4
$14.8K Hold
140
﹤0.01% 542
2024
Q3
$15.1K Hold
140
﹤0.01% 542
2024
Q2
$15.2K Hold
140
﹤0.01% 519
2024
Q1
$18.5K Hold
140
0.01% 464
2023
Q4
$17K Hold
140
0.01% 461
2023
Q3
$15.7K Hold
140
0.01% 446
2023
Q2
$20.4K Hold
140
0.01% 412
2023
Q1
$18.1K Hold
140
0.01% 409
2022
Q4
$17.9K Hold
140
0.01% 388
2022
Q3
$15K Hold
140
0.01% 396
2022
Q2
$15K Hold
140
0.01% 395
2022
Q1
$18K Sell
140
-4
-3% -$482 0.01% 409
2021
Q4
$18K Hold
144
0.01% 352
2021
Q3
$20K Hold
144
0.02% 261
2021
Q2
$23K Buy
+144
New +$23.3K 0.02% 252
2020
Q4
$22K Buy
+144
New +$20.3K 0.02% 242

Other funds holding ZBH

Addison Advisors's ZBH Position: Q1 2026 in Review

Addison Advisors held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 140 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #619.

Addison Advisors first reported a position in ZBH in Q4 2020 and has held it in 21 quarters since. The position peaked at $23K in Q2 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Addison Advisors held 140 shares of Zimmer Biomet worth $12.7K as of Q1 2026.
  • Addison Advisors left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up ﹤0.01% of Addison Advisors's portfolio in Q1 2026, its #619 holding.
  • Addison Advisors first reported a position in Zimmer Biomet in Q4 2020 and has held it in 21 quarters since.
  • Addison Advisors's Zimmer Biomet position peaked at $23K in Q2 2021.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Addison Advisors's 13F filing for Q1 2026, filed 8 May 2026.